Stephanie Harris Applebaum, MD | |
12935 Gregory St, Blue Island, IL 60406-2428 | |
(708) 597-2000 | |
Not Available |
Full Name | Stephanie Harris Applebaum |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 12935 Gregory St, Blue Island, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063445286 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephanie Harris Applebaum, MD 1613 Cambridge Ave, Flossmoor, IL 60422-2127 Ph: (708) 799-1471 | Stephanie Harris Applebaum, MD 12935 Gregory St, Blue Island, IL 60406-2428 Ph: (708) 597-2000 |
News Archive
Theories have long proposed that testosterone influences competition among males trying to attract females. Findings from a recent study at Wayne State University give a clearer understanding of the links between testosterone and human mating behavior, and how testosterone is associated with dominance and competitive success when men battle for the attention of an attractive woman.
A program that bundled two generic, low-cost drugs - a cholesterol-lowering statin and a blood pressure-lowering drug - and gave daily doses to 68,560 people with diabetes or heart disease for two years is estimated to have prevented 1,271 heart attacks and strokes in the first year following the study period, according to a Kaiser Permanente study published online in the American Journal of Managed Care.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.
The estimated 10 percent of women in Western nations who enter menopause before age 45 have an elevated risk of cardiovascular disease, as well as lower fertility. Now epidemiologist Elizabeth Bertone-Johnson at the University of Massachusetts Amherst is conducting the first large study to investigate whether vitamin D deficiency, inflammatory factors, hormones and other factors are associated with risk of early menopause, funded by NIH.
› Verified 1 days ago